Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV
批准号:
9116289
负责人:
TODD M BULL
金额:
$66.14万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-26 至 2018-07-31
关键词:
AddressAgeAllelesAmino Acid SubstitutionAmino AcidsApoptosisBiological MarkersBloodBlood BanksBrainCDKN1A geneCaliforniaCardiac Catheterization ProceduresCell ProliferationCell physiologyCellsChronicClinicalClone CellsCoculture TechniquesCollaborationsColoradoComplicationDataDevelopmentDown-RegulationEchocardiographyEndothelial CellsEnvironmentEvolutionExerciseExposure toFrequenciesFunctional disorderGene ExpressionGenetic PolymorphismGenetic TranscriptionHIVHIV-1HealthHumanImmuneImmune responseImmune systemIn VitroIndividualInfectionLungLung Lavage FluidLung diseasesLymphocyte FunctionMacacaMeasuresMitogensModelingMolecularMolecular CloningMolecular ProfilingNational Heart, Lung, and Blood InstitutePathogenesisPatientsPeripheral Blood Mononuclear CellPhenotypePlasmaPopulationPositioning AttributeProcessPropertyProtein KinaseProteinsPulmonary HypertensionPulmonary artery structureRecombinantsReportingResearchResistanceRestRiskRoleSamplingSan FranciscoScientistSeminal fluidSignal Transduction PathwaySiteSpecimenSystolic PressureT cell responseT-Cell ReceptorT-LymphocyteUniversitiesVariantVascular DiseasesVascular Endothelial CellVascular remodelingViralViral ProteinsVirionVirusbiobankcell injurycohortdesigngenetic varianthemodynamicsin vivonef Genesnef Proteinnovel therapeuticsperipheral bloodpressurepulmonary arterial hypertensionpulmonary artery endothelial cellreceptor densityreceptor expressionreceptor functionrepositoryresponse to injurytool
中文摘要
描述(由申请人提供):随着艾滋病毒感染者的年龄不断增长,非传染性并发症的频率增加。尽管1987年首次描述了患者病例,但对艾滋病毒相关性肺动脉高压(PAH-HIV)的发病机制知之甚少。慢性暴露于HIV-1 Nef等病毒产物和HIV诱导的肺部免疫失调可能会导致肺血管疾病,特别是通过它们对肺内皮细胞(EC)的影响。我们小组首次将HIV-1nef蛋白与PAH-HIV血管重塑的发病机制联系起来。我们纵向跟踪了34名PAH-HIV患者,收集了连续的临床和超声心动图;我们创建和管理了血浆、支气管灌洗液和细胞库。我们从PAH患者、肺动脉收缩压升高的患者和非PAH HIV感染患者的血液和肺样本中对nef基因进行了测序。我们发现Nef蛋白中的氨基酸替换在统计学上与PAH表型相关;这些替换聚集在Nef功能结构域周围,可能会干扰Nef适配器的功能。在本申请中初步报道的进一步研究表明,特定的氨基酸特征
与外周相比,肺脏占优势。肺可能是病毒逃避免疫反应的保护性环境;此外,特定的nef等位基因会增强T细胞反应,导致肺血管内皮细胞增殖/凋亡,扰乱信号转导途径,导致血管重构。我们假设NEF的等位基因变异将对T细胞和肺内皮细胞功能产生影响。我们建议1)用含有初级nef等位基因的分子克隆病毒粒子感染T细胞,并测量T细胞受体密度;2)将人的肺动脉内皮细胞与感染的T细胞共培养或转染nef分子克隆,检测内皮细胞的基因表达、凋亡和增殖情况;3)确定肺是否是nef序列进化的保护室。这些研究将检验来自PAH-HIV个体的包含这些氨基酸替代的nef等位基因的功能特性。
本申请中提出的研究将使用现有的生物标本和克隆的nef等位基因来研究HIV-nef在PAH-HIV发病机制中影响肺血管重构的机制。我们的研究项目,与基础和临床科学家相结合,很好地解决了nef病毒蛋白和免疫失调是如何导致艾滋病毒肺部并发症的因素。
英文摘要
DESCRIPTION (provided by applicant): As HIV-infected individuals continue to age, non-infectious complications increase in frequency. Despite the first descriptions of patient cases in 1987, little is known about the pathogenesis of pulmonary hypertension associated with HIV (PAH-HIV). Chronic exposure to viral products such as HIV-1 Nef and HIV-induced immune deregulation in the lung may contribute to pulmonary vascular disease, particularly through their impact on pulmonary endothelial cells (EC). Our group was the first to associate the HIV-1 nef protein with the pathogenesis of vascular remodeling PAH-HIV. We longitudinally followed 34 individuals with PAH-HIV and collected sequential clinical and echocardiographic; we created and curated a repository of plasma, bronchial lavage fluid and cells. We sequenced the nef gene from blood and lung samples from patients with PAH, elevated pulmonary artery systolic pressures and from non- PAH HIV infected. We found amino acid substitutions in the Nef protein statistically associated with the PAH phenotype; these substitutions clustered around Nef functional domains that potentially interfere with Nef adaptor functions. Further studies, which are preliminarily reported in this application, suggest that particular amino acid signatures
predominate in the lungs compared with the periphery. The lung may be a protected environment that allows the virus to evade immune responses; furthermore, particular nef alleles will enhance T cell responses and result in pulmonary vascular endothelial cell proliferation/apoptosis, disrupt signal transduction pathways and result in vascular remodeling. We hypothesize that allelic variants of nef will have an impact on T cell and pulmonary endothelial cell function. We propose to 1) infect T cells with molecularly cloned virions containing primary nef alleles and measure T cell receptor density; 2) human pulmonary artery endothelial cells will be co-cultured with infected T cells or transfected with nef molecular clone and endothelial cell gene expression, apoptosis and proliferation measured and 3) determine whether the lung is a protected compartment for evolution of nef sequences. These studies will examine the functional properties of nef alleles containing these amino acid substitutions from PAH-HIV individuals.
The studies proposed in this application will use existing biospecimens and cloned nef alleles to examine the mechanisms whereby HIV-nef influences pulmonary vascular remodeling in the pathogenesis of PAH-HIV. Our research tem, with a combination of basic and clinician scientists is well poised to address how the nef viral protein and immune dysregulation are contributing factors to this lung complication of HIV.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV
-
批准号:8743258
-
项目类别:
-
资助金额:$66.42万
-
财政年份:2013
-
负责人:TODD M BULL
-
依托单位:
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV
-
批准号:8639346
-
项目类别:
-
资助金额:$66.43万
-
财政年份:2013
-
负责人:TODD M BULL
-
依托单位:
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV
-
批准号:9323516
-
项目类别:
-
资助金额:$65.25万
-
财政年份:2013
-
负责人:TODD M BULL
-
依托单位:
Thomas L. Petty Conference: Mechanics and Mechanisms of Pulmonary Hypertension
-
批准号:8318416
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2012
-
负责人:TODD M BULL
-
依托单位:
Fibroblasts and Mononuclear Fibrogenic Cells Drive Right Ventricular Pulmonary Ar
-
批准号:8354554
-
项目类别:
-
资助金额:$68.11万
-
财政年份:2012
-
负责人:TODD M BULL
-
依托单位:
Fibroblasts and Mononuclear Fibrogenic Cells Drive Right Ventricular Pulmonary Ar
-
批准号:8529612
-
项目类别:
-
资助金额:$65.05万
-
财政年份:2012
-
负责人:TODD M BULL
-
依托单位:
10th International Pulmonary Hypertension Conference: Scientific Sessions
-
批准号:8400297
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2012
-
负责人:TODD M BULL
-
依托单位:
Fibroblasts and Mononuclear Fibrogenic Cells Drive Right Ventricular Pulmonary Ar
-
批准号:9120907
-
项目类别:
-
资助金额:$68.77万
-
财政年份:2012
-
负责人:TODD M BULL
-
依托单位:
Fibroblasts and Mononuclear Fibrogenic Cells Drive Right Ventricular Pulmonary Ar
-
批准号:8688340
-
项目类别:
-
资助金额:$67.18万
-
财政年份:2012
-
负责人:TODD M BULL
-
依托单位:
Peripheral Blood Cells in Severe Pulmonary Hypertention
-
批准号:6962221
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2005
-
负责人:TODD M BULL
-
依托单位:
Peripheral Blood Cells in Severe Pulmonary Hypertention
-
批准号:7126496
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2005
-
负责人:TODD M BULL
-
依托单位:
Peripheral Blood Cells in Severe Pulmonary Hypertention
-
批准号:7681206
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2005
-
负责人:TODD M BULL
-
依托单位:
Peripheral Blood Cells in Severe Pulmonary Hypertention
-
批准号:7275434
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2005
-
负责人:TODD M BULL
-
依托单位:
Peripheral Blood Cells in Severe Pulmonary Hypertention
-
批准号:7494456
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2005
-
负责人:TODD M BULL
-
依托单位:
Human Subjects Core B
-
批准号:8931336
-
项目类别:
-
资助金额:$21.94万
-
财政年份:--
-
负责人:TODD M BULL
-
依托单位:
Human Subjects Core B
-
批准号:9123644
-
项目类别:
-
资助金额:$21.94万
-
财政年份:--
-
负责人:TODD M BULL
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: